[FREE REPORT] Disruptive Business Models in Personalized Medicine
Araceli Giner Arroyo
Marketing Manager at ATA Insights [Renewable Energy Specialists]
Personalized medicine is an unmissable opportunity that is set to be worth $2.5tn in 2022. Demonstrating its short and long term cost-opportunity is the key, but in a such a changeable sector, how can you find the accurate strategy and business model?
Genetic-Insider's report reveals the top trends in PM’ business models. In this report you'll learn:
- Which is the real impact of PM in the healthcare system
- The new business models and paradigms that are appearing to stay
- PLUS! It includes an exclusive interview with Jorge León (President and CEO at Leomics Associates, and founder of Quest Diagnostics) exploring the commercial strategy to keep on improving the Personaliced Medicine industry
Click here to download: https://goo.gl/z3Q37L